Welcome to Medications.com

Accounting Changes Send Schering-Plough to a Loss - New York Times

Significant profit sources for Schering-Plough include the arthritis treatment Remicade and the allergy treatment Nasonex. Quarterly Remicade sales rose 35 ...

http://www.nytimes.com/2008/02/13... | Posted: Wed Feb 13 00:08:35 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea